Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents

Despite advances in the development of clinical agents for treating Mantle Cell Lymphoma (MCL), treatment of MCL remains a challenge due to complexity and frequent relapse associated with MCL. The incorporation of conventional and novel diagnostic approaches such as genomic sequencing have helped im...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Inamdar, Arati A., Goy, Andre, Ayoub, Nehad M., Attia, Christen, Oton, Lucia, Taruvai, Varun, Costales, Mark, Lin, Yu-Ting, Pecora, Andrew, Suh, Stephen K.
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217048/
https://ncbi.nlm.nih.gov/pubmed/27119356
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8961
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items